AU2001261333A1 - Cetp taqib polymorphism as risk factor for development of coronary heart disease - Google Patents
Cetp taqib polymorphism as risk factor for development of coronary heart diseaseInfo
- Publication number
- AU2001261333A1 AU2001261333A1 AU2001261333A AU6133301A AU2001261333A1 AU 2001261333 A1 AU2001261333 A1 AU 2001261333A1 AU 2001261333 A AU2001261333 A AU 2001261333A AU 6133301 A AU6133301 A AU 6133301A AU 2001261333 A1 AU2001261333 A1 AU 2001261333A1
- Authority
- AU
- Australia
- Prior art keywords
- cetp
- development
- heart disease
- risk factor
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000029078 coronary artery disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20346700P | 2000-05-11 | 2000-05-11 | |
| US60203467 | 2000-05-11 | ||
| PCT/US2001/015013 WO2001085999A1 (en) | 2000-05-11 | 2001-05-10 | Cetp taqib polymorphism as risk factor for development of coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001261333A1 true AU2001261333A1 (en) | 2001-11-20 |
Family
ID=22754133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001261333A Abandoned AU2001261333A1 (en) | 2000-05-11 | 2001-05-10 | Cetp taqib polymorphism as risk factor for development of coronary heart disease |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020034752A1 (en) |
| AU (1) | AU2001261333A1 (en) |
| WO (1) | WO2001085999A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108546756A (en) * | 2018-05-16 | 2018-09-18 | 上海中溢精准医疗科技有限公司 | A kind of single nucleotide polymorphism gene tester |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0939136A1 (en) * | 1998-01-07 | 1999-09-01 | Academisch Ziekenhuis bij de Universiteit van Amsterdam | Assay for predicting the angiographic response to lipid-lowering therapy in patients |
-
2001
- 2001-05-10 US US09/852,980 patent/US20020034752A1/en not_active Abandoned
- 2001-05-10 AU AU2001261333A patent/AU2001261333A1/en not_active Abandoned
- 2001-05-10 WO PCT/US2001/015013 patent/WO2001085999A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085999A1 (en) | 2001-11-15 |
| US20020034752A1 (en) | 2002-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| EE200100536A (en) | Process for the preparation of amine-platinum complexes | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| AU2002366666A1 (en) | Medical after sales support | |
| AU2001233208A1 (en) | Human sulfatases | |
| AU6932000A (en) | Tacrine derivatives for treating alzheimer's disease | |
| AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
| NO20013818L (en) | Microbial process for the preparation of pravastatin | |
| AU7408301A (en) | Novel target genes for diseases of the heart | |
| AU2001273661A1 (en) | Methods of screening for alzheimer's disease | |
| AU2002232419A1 (en) | Clinician's assistant system | |
| AU5698400A (en) | Sulphamate compounds | |
| AU5307099A (en) | Health pool | |
| HUP0203407A3 (en) | Process for the preparation of pyrazolopyridazine derivatives | |
| AU2001261333A1 (en) | Cetp taqib polymorphism as risk factor for development of coronary heart disease | |
| AU7918200A (en) | Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines | |
| AU1806001A (en) | Oxidation process | |
| AU2003299101A1 (en) | Compounds for the treatment of alzheimer's disease | |
| AU3454900A (en) | Compositions for reducing blood cholesterol | |
| EP1426762A4 (en) | Remedies for heart diseases | |
| AU4917700A (en) | Halogen compounds | |
| NO20020328D0 (en) | Process for the preparation of 4-cyano-2-aminomethylthiazole | |
| AU1549001A (en) | Remedies for periodontosis | |
| AUPQ048799A0 (en) | Diagnosis of cardiovascular disease | |
| AU3421100A (en) | Pyrazole alkylamides |